IGHV unmutated CLL B cells are more prone to spontaneous apoptosis and subject to environmental prosurvival signals than mutated CLL B cells
Tumor cells in chronic lymphocytic leukemia (CLL) are more prone to apoptosis when cultured ex vivo, because they lack prosurvival signals furnished in vivo via B-cell receptor (BCR)-dependent and -independent pathways. This study compared the susceptibility of unmutated (UM) and mutated (M) CLL B c...
Saved in:
Published in | Leukemia Vol. 25; no. 5; pp. 828 - 837 |
---|---|
Main Authors | , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
01.05.2011
Nature Publishing Group |
Subjects | |
Online Access | Get full text |
ISSN | 0887-6924 1476-5551 1476-5551 |
DOI | 10.1038/leu.2011.12 |
Cover
Abstract | Tumor cells in chronic lymphocytic leukemia (CLL) are more prone to apoptosis when cultured
ex vivo,
because they lack prosurvival signals furnished
in vivo
via B-cell receptor (BCR)-dependent and -independent pathways. This study compared the susceptibility of unmutated (UM) and mutated (M) CLL B cells to spontaneous apoptosis and prosurvival signals. UM CLL B cells showed a significantly higher rate of spontaneous apoptosis than M CLL B cells. Nuclear factor-kB (NF-kB) was rapidly inactivated, and B-cell leukemia/lymphoma 2 (Bcl-2) expression progressively down-regulated in the UM CLL B cells. CD40-Ligand, interleukin-4 and stromal cells significantly improved their viability and partially recovered Bcl-2, but not NF-kB expression. Peripheral blood mononuclear cells also offered protection of UM CLL B cells, and recovered both NF-kB and Bcl-2 expression. T cells, rather than nurse-like cells, were responsible for protecting UM CLL B cells by means of cell-to-cell contact and soluble factors. Despite their more aggressive features, UM CLL B cells are more susceptible to spontaneous apoptosis and depend from environmental prosurvival signals. This vulnerability of UM CLL B cells can be exploited as a selective target of therapeutic interventions. |
---|---|
AbstractList | Tumor cells in chronic lymphocytic leukemia (CLL) are more prone to apoptosis when cultured ex vivo, because they lack prosurvival signals furnished in vivo via B-cell receptor (BCR)-dependent and -independent pathways. This study compared the susceptibility of unmutated (UM) and mutated (M) CLL B cells to spontaneous apoptosis and prosurvival signals. UM CLL B cells showed a significantly higher rate of spontaneous apoptosis than M CLL B cells. Nuclear factor-kB (NF-kB) was rapidly inactivated, and B-cell leukemia/lymphoma 2 (Bcl-2) expression progressively down-regulated in the UM CLL B cells. CD40-Ligand, interleukin-4 and stromal cells significantly improved their viability and partially recovered Bcl-2, but not NF-kB expression. Peripheral blood mononuclear cells also offered protection of UM CLL B cells, and recovered both NF-kB and Bcl-2 expression. T cells, rather than nurse-like cells, were responsible for protecting UM CLL B cells by means of cell-to-cell contact and soluble factors. Despite their more aggressive features, UM CLL B cells are more susceptible to spontaneous apoptosis and depend from environmental prosurvival signals. This vulnerability of UM CLL B cells can be exploited as a selective target of therapeutic interventions. Tumor cells in chronic lymphocytic leukemia (CLL) are more prone to apoptosis when cultured ex vivo, because they lack prosurvival signals furnished in vivo via B-cell receptor (BCR)-dependent and -independent pathways. This study compared the susceptibility of unmutated (UM) and mutated (M) CLL B cells to spontaneous apoptosis and prosurvival signals. UM CLL B cells showed a significantly higher rate of spontaneous apoptosis than M CLL B cells. Nuclear factor-κB (NF-κB) was rapidly inactivated, and B-cell leukemia/lymphoma 2 (Bcl-2) expression progressively down-regulated in the UM CLL B cells. CD40-Ligand, interleukin-4 and stromal cells significantly improved their viability and partially recovered Bcl-2, but not NF-κB expression. Peripheral blood mononuclear cells also offered protection of UM CLL B cells, and recovered both NF-κB and Bcl-2 expression. T cells, rather than nurse-like cells, were responsible for protecting UM CLL B cells by means of cell-to-cell contact and soluble factors. Despite their more aggressive features, UM CLL B cells are more susceptible to spontaneous apoptosis and depend from environmental pro-survival signals. This vulnerability of UM CLL B cells can be exploited as a selective target of therapeutic interventions. Leukemia (2011) 25, 828-837; doi: 10.1038/leu.2011.12; published online 4 March 2011 Keywords: chronic lymphocytic leukemia; immunoglobulin mutational status; tumor microenvironment Tumor cells in chronic lymphocytic leukemia (CLL) are more prone to apoptosis when cultured ex vivo, because they lack prosurvival signals furnished in vivo via B-cell receptor (BCR)-dependent and -independent pathways. This study compared the susceptibility of unmutated (UM) and mutated (M) CLL B cells to spontaneous apoptosis and prosurvival signals. UM CLL B cells showed a significantly higher rate of spontaneous apoptosis than M CLL B cells. Nuclear factor-kB (NF-kB) was rapidly inactivated, and B-cell leukemia/lymphoma 2 (Bcl-2) expression progressively down-regulated in the UM CLL B cells. CD40-Ligand, interleukin-4 and stromal cells significantly improved their viability and partially recovered Bcl-2, but not NF-kB expression. Peripheral blood mononuclear cells also offered protection of UM CLL B cells, and recovered both NF-kB and Bcl-2 expression. T cells, rather than nurse-like cells, were responsible for protecting UM CLL B cells by means of cell-to-cell contact and soluble factors. Despite their more aggressive features, UM CLL B cells are more susceptible to spontaneous apoptosis and depend from environmental prosurvival signals. This vulnerability of UM CLL B cells can be exploited as a selective target of therapeutic interventions. Tumor cells in chronic lymphocytic leukemia (CLL) are more prone to apoptosis when cultured ex vivo, because they lack prosurvival signals furnished in vivo via B-cell receptor (BCR)-dependent and -independent pathways. This study compared the susceptibility of unmutated (UM) and mutated (M) CLL B cells to spontaneous apoptosis and prosurvival signals. UM CLL B cells showed a significantly higher rate of spontaneous apoptosis than M CLL B cells. Nuclear factor-kB (NF-kB) was rapidly inactivated, and B-cell leukemia/lymphoma 2 (Bcl-2) expression progressively down-regulated in the UM CLL B cells. CD40-Ligand, interleukin-4 and stromal cells significantly improved their viability and partially recovered Bcl-2, but not NF-kB expression. Peripheral blood mononuclear cells also offered protection of UM CLL B cells, and recovered both NF-kB and Bcl-2 expression. T cells, rather than nurse-like cells, were responsible for protecting UM CLL B cells by means of cell-to-cell contact and soluble factors. Despite their more aggressive features, UM CLL B cells are more susceptible to spontaneous apoptosis and depend from environmental prosurvival signals. This vulnerability of UM CLL B cells can be exploited as a selective target of therapeutic interventions.Tumor cells in chronic lymphocytic leukemia (CLL) are more prone to apoptosis when cultured ex vivo, because they lack prosurvival signals furnished in vivo via B-cell receptor (BCR)-dependent and -independent pathways. This study compared the susceptibility of unmutated (UM) and mutated (M) CLL B cells to spontaneous apoptosis and prosurvival signals. UM CLL B cells showed a significantly higher rate of spontaneous apoptosis than M CLL B cells. Nuclear factor-kB (NF-kB) was rapidly inactivated, and B-cell leukemia/lymphoma 2 (Bcl-2) expression progressively down-regulated in the UM CLL B cells. CD40-Ligand, interleukin-4 and stromal cells significantly improved their viability and partially recovered Bcl-2, but not NF-kB expression. Peripheral blood mononuclear cells also offered protection of UM CLL B cells, and recovered both NF-kB and Bcl-2 expression. T cells, rather than nurse-like cells, were responsible for protecting UM CLL B cells by means of cell-to-cell contact and soluble factors. Despite their more aggressive features, UM CLL B cells are more susceptible to spontaneous apoptosis and depend from environmental prosurvival signals. This vulnerability of UM CLL B cells can be exploited as a selective target of therapeutic interventions. Tumor cells in chronic lymphocytic leukemia (CLL) are more prone to apoptosis when cultured ex vivo, because they lack prosurvival signals furnished in vivo via B-cell receptor (BCR)-dependent and -independent pathways. This study compared the susceptibility of unmutated (UM) and mutated (M) CLL B cells to spontaneous apoptosis and prosurvival signals. UM CLL B cells showed a significantly higher rate of spontaneous apoptosis than M CLL B cells. Nuclear factor-κB (NF-κB) was rapidly inactivated, and B-cell leukemia/lymphoma 2 (Bcl-2) expression progressively down-regulated in the UM CLL B cells. CD40-Ligand, interleukin-4 and stromal cells significantly improved their viability and partially recovered Bcl-2, but not NF-κB expression. Peripheral blood mononuclear cells also offered protection of UM CLL B cells, and recovered both NF-κB and Bcl-2 expression. T cells, rather than nurse-like cells, were responsible for protecting UM CLL B cells by means of cell-to-cell contact and soluble factors. Despite their more aggressive features, UM CLL B cells are more susceptible to spontaneous apoptosis and depend from environmental pro-survival signals. This vulnerability of UM CLL B cells can be exploited as a selective target of therapeutic interventions. Leukemia (2011) 25, 828-837; doi: 10.1038/leu.2011.12; published online 4 March 2011 |
Audience | Academic |
Author | Vitale, C Boccadoro, M Drandi, D Castella, B Massaia, M Riganti, C Peola, S Griggio, V Rigoni, M Ladetto, M Pantaleoni, F Foglietta, M Coscia, M Bosia, A |
Author_xml | – sequence: 1 givenname: M surname: Coscia fullname: Coscia, M email: marta.coscia@unito.it organization: Divisione di Ematologia dell’Università di Torino, Azienda Ospedaliero Universitaria San Giovanni Battista di Torino, Laboratorio di Ematologia Oncologica, Centro di Ricerca Medicina Sperimentale (CeRMS), Azienda Ospedaliero Universitaria San Giovanni Battista di Torino – sequence: 2 givenname: F surname: Pantaleoni fullname: Pantaleoni, F organization: Laboratorio di Ematologia Oncologica, Centro di Ricerca Medicina Sperimentale (CeRMS), Azienda Ospedaliero Universitaria San Giovanni Battista di Torino – sequence: 3 givenname: C surname: Riganti fullname: Riganti, C organization: Dipartimento di Genetica, Biologia e Biochimica, Università di Torino – sequence: 4 givenname: C surname: Vitale fullname: Vitale, C organization: Divisione di Ematologia dell’Università di Torino, Azienda Ospedaliero Universitaria San Giovanni Battista di Torino, Laboratorio di Ematologia Oncologica, Centro di Ricerca Medicina Sperimentale (CeRMS), Azienda Ospedaliero Universitaria San Giovanni Battista di Torino – sequence: 5 givenname: M surname: Rigoni fullname: Rigoni, M organization: Laboratorio di Ematologia Oncologica, Centro di Ricerca Medicina Sperimentale (CeRMS), Azienda Ospedaliero Universitaria San Giovanni Battista di Torino – sequence: 6 givenname: S surname: Peola fullname: Peola, S organization: Laboratorio di Ematologia Oncologica, Centro di Ricerca Medicina Sperimentale (CeRMS), Azienda Ospedaliero Universitaria San Giovanni Battista di Torino – sequence: 7 givenname: B surname: Castella fullname: Castella, B organization: Laboratorio di Ematologia Oncologica, Centro di Ricerca Medicina Sperimentale (CeRMS), Azienda Ospedaliero Universitaria San Giovanni Battista di Torino – sequence: 8 givenname: M surname: Foglietta fullname: Foglietta, M organization: Laboratorio di Ematologia Oncologica, Centro di Ricerca Medicina Sperimentale (CeRMS), Azienda Ospedaliero Universitaria San Giovanni Battista di Torino – sequence: 9 givenname: V surname: Griggio fullname: Griggio, V organization: Divisione di Ematologia dell’Università di Torino, Azienda Ospedaliero Universitaria San Giovanni Battista di Torino, Laboratorio di Ematologia Oncologica, Centro di Ricerca Medicina Sperimentale (CeRMS), Azienda Ospedaliero Universitaria San Giovanni Battista di Torino – sequence: 10 givenname: D surname: Drandi fullname: Drandi, D organization: Divisione di Ematologia dell’Università di Torino, Azienda Ospedaliero Universitaria San Giovanni Battista di Torino – sequence: 11 givenname: M surname: Ladetto fullname: Ladetto, M organization: Divisione di Ematologia dell’Università di Torino, Azienda Ospedaliero Universitaria San Giovanni Battista di Torino – sequence: 12 givenname: A surname: Bosia fullname: Bosia, A organization: Dipartimento di Genetica, Biologia e Biochimica, Università di Torino – sequence: 13 givenname: M surname: Boccadoro fullname: Boccadoro, M organization: Divisione di Ematologia dell’Università di Torino, Azienda Ospedaliero Universitaria San Giovanni Battista di Torino – sequence: 14 givenname: M surname: Massaia fullname: Massaia, M organization: Divisione di Ematologia dell’Università di Torino, Azienda Ospedaliero Universitaria San Giovanni Battista di Torino, Laboratorio di Ematologia Oncologica, Centro di Ricerca Medicina Sperimentale (CeRMS), Azienda Ospedaliero Universitaria San Giovanni Battista di Torino |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=24166145$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/21372840$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkk1v00AQhi1URNPCiTuyQMABHPbD--FjiaCtFIkLcLU2m3Gykb12veug_gd-NGMlEFqlqizZK8_zzsy-M2fJiW89JMlLSqaUcP2phmHKCKVTyp4kE5ormQkh6EkyIVqrTBYsP03OQtgQMgbls-SUUa6Yzskk-X19efUzHXwzRBNhmc7m8_RzaqGuQ2p6SJsWX12PFdPYpqFrfTQe2gGjXdvFNjg8-WUahsUGbBwh8FuHggYQrUdtGPqt2-I5uJU3mDiujU-PVHyePK0wDi_23_Pkx9cv32dX2fzb5fXsYp5ZoVTMGJHMMs5ASMOh0NyyXGmjgVOTcyaYlkaTgjFT2IpSUAvgwMDaxbKQii34efJxl3fwnbn9Zeq67HrXmP62pKQcTS3R1HI0taQM8fc7HO9yM0CIZePC2PDOiVKrnOq8oPJxUkomKBcEydf3yE079KM7CAlFKY4HoTcPQUzmAkfICT9QK1ND6XzVxt7YsXB5wTAVE5oqpKZHKHyW0DiL860c_r8jePefYA2mjuvQ1kN0rQ93wVf7LodFA8t_Vv5dMgTe7gETrKmr3njrwoHLqZQ0F8h92HEWdyb0UD0yFXqPtg43CrvDi7n6Ac1-8AEz-xX0B0OP4X8AiqwK7w |
CODEN | LEUKED |
CitedBy_id | crossref_primary_10_1002_ijc_28974 crossref_primary_10_1007_s00109_013_1081_6 crossref_primary_10_1038_leu_2012_44 crossref_primary_10_1016_j_blre_2016_10_001 crossref_primary_10_3390_cancers15194736 crossref_primary_10_3109_10428194_2011_610014 crossref_primary_10_1186_s12943_014_0286_9 crossref_primary_10_18632_oncotarget_8672 crossref_primary_10_2119_molmed_2011_00360 crossref_primary_10_1517_17530059_2012_637108 crossref_primary_10_1016_j_anndiagpath_2018_02_006 crossref_primary_10_1182_asheducation_2011_1_96 crossref_primary_10_1182_blood_2012_03_417519 crossref_primary_10_1182_blood_2012_08_452607 crossref_primary_10_3390_pharmaceutics16010055 crossref_primary_10_3390_cancers17010072 crossref_primary_10_3390_cancers14133087 crossref_primary_10_1007_s00262_012_1300_y crossref_primary_10_1016_j_celrep_2019_10_106 crossref_primary_10_1038_s41598_021_82609_2 crossref_primary_10_1080_10408363_2019_1600468 crossref_primary_10_18632_oncotarget_4006 crossref_primary_10_3390_jcm12072731 crossref_primary_10_1371_journal_pone_0124936 crossref_primary_10_1007_s00277_013_1967_y crossref_primary_10_1111_bjh_12580 crossref_primary_10_1371_journal_pone_0023758 crossref_primary_10_1007_s10637_011_9740_3 crossref_primary_10_1182_blood_2012_02_409110 crossref_primary_10_1080_10428194_2020_1811274 crossref_primary_10_1182_blood_2013_02_485540 crossref_primary_10_18632_oncotarget_3905 crossref_primary_10_1158_1078_0432_CCR_15_3099 crossref_primary_10_3389_frhem_2022_1004717 crossref_primary_10_1053_j_seminhematol_2014_05_002 crossref_primary_10_3390_cancers13122883 crossref_primary_10_1016_S0001_5814_12_70005_1 crossref_primary_10_1371_journal_pone_0109533 crossref_primary_10_1038_leu_2015_305 crossref_primary_10_1182_blood_2012_02_414060 crossref_primary_10_1182_blood_2012_08_447904 crossref_primary_10_3390_cancers12020524 crossref_primary_10_1038_leu_2014_188 crossref_primary_10_1016_j_exphem_2020_12_007 crossref_primary_10_1038_s41598_023_44039_0 crossref_primary_10_1016_j_drup_2019_100670 crossref_primary_10_1111_j_1365_2141_2012_09191_x crossref_primary_10_1002_med_21341 crossref_primary_10_1016_j_hoc_2012_12_002 crossref_primary_10_3389_fonc_2020_01422 crossref_primary_10_3390_cells10020217 |
Cites_doi | 10.2174/1568009043333032 10.1182/blood-2002-06-1822 10.1093/emboj/cdg004 10.1146/annurev.immunol.021908.132641 10.1172/JCI24176 10.1200/JCO.2008.19.1114 10.1056/NEJMra041720 10.4049/jimmunol.164.4.2200 10.1002/ijc.21832 10.1038/ni842 10.1182/blood-2009-06-225326 10.1182/blood-2007-06-094029 10.1097/CJI.0b013e318197b5e4 10.1074/jbc.M410994200 10.1111/j.1365-2567.2006.02377.x 10.1084/jem.177.4.925 10.1182/blood-2004-07-2669 10.1111/j.1365-2141.2008.07363.x 10.1182/blood-2005-08-3182 10.1182/blood.V99.3.1030 10.1093/emboj/cdf542 10.1158/1541-7786.MCR-08-0142 10.1046/j.1365-2141.1996.00305.x 10.1182/blood-2004-12-4918 10.1159/000087886 10.1126/science.1062677 10.1016/S0301-472X(02)01046-9 10.1111/j.1365-2796.2008.02030.x 10.1182/blood-2002-03-0746 10.1093/humrep/deh806 10.1182/blood-2009-07-233718 10.1200/JCO.2007.15.4393 10.1182/blood-2007-11-125278 10.1158/1078-0432.CCR-08-1673 10.1038/sj.leu.2404544 10.1182/blood.V99.5.1666 10.1111/j.1365-2567.2005.02117.x 10.1084/jem.176.5.1319 10.1182/blood-2004-03-0889 10.1016/j.it.2004.03.008 10.1182/blood.V96.8.2655 10.1182/blood.V94.6.1848 10.1182/blood.V87.10.4382.bloodjournal87104382 10.1182/blood.V94.6.1840 10.1182/blood.V91.7.2387 |
ContentType | Journal Article |
Copyright | Macmillan Publishers Limited 2011 2015 INIST-CNRS COPYRIGHT 2011 Nature Publishing Group Macmillan Publishers Limited 2011. Copyright Nature Publishing Group May 2011 |
Copyright_xml | – notice: Macmillan Publishers Limited 2011 – notice: 2015 INIST-CNRS – notice: COPYRIGHT 2011 Nature Publishing Group – notice: Macmillan Publishers Limited 2011. – notice: Copyright Nature Publishing Group May 2011 |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 3V. 7QL 7RV 7T5 7T7 7TM 7TO 7U9 7X7 7XB 88E 8AO 8C1 8FD 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI C1K CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ H94 HCIFZ K9. KB0 LK8 M0S M1P M7N M7P NAPCQ P64 PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS 7X8 ADTOC UNPAY |
DOI | 10.1038/leu.2011.12 |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) Nursing & Allied Health Database Immunology Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) Nucleic Acids Abstracts Oncogenes and Growth Factors Abstracts Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database Technology Research Database ProQuest SciTech Collection ProQuest Natural Science Collection ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection Environmental Sciences and Pollution Management ProQuest One ProQuest Central Korea Engineering Research Database Proquest Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Biological Sciences ProQuest Health & Medical Collection Medical Database Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database Nursing & Allied Health Premium Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic Unpaywall for CDI: Periodical Content Unpaywall |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Central Student Oncogenes and Growth Factors Abstracts ProQuest Central Essentials Nucleic Acids Abstracts SciTech Premium Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest One Applied & Life Sciences Health Research Premium Collection Natural Science Collection Health & Medical Research Collection Biological Science Collection Industrial and Applied Microbiology Abstracts (Microbiology A) ProQuest Central (New) ProQuest Medical Library (Alumni) Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) Engineering Research Database ProQuest One Academic ProQuest One Academic (New) Technology Research Database ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central ProQuest Health & Medical Research Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) AIDS and Cancer Research Abstracts ProQuest Public Health ProQuest Nursing & Allied Health Source ProQuest SciTech Collection ProQuest Medical Library Immunology Abstracts ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE AIDS and Cancer Research Abstracts ProQuest Central Student ProQuest Central Student MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: UNPAY name: Unpaywall url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/ sourceTypes: Open Access Repository – sequence: 4 dbid: BENPR name: ProQuest Central Database Suite (ProQuest) url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1476-5551 |
EndPage | 837 |
ExternalDocumentID | 10.1038/leu.2011.12 2342897901 A257125817 21372840 24166145 10_1038_leu_2011_12 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | Italy |
GeographicLocations_xml | – name: Italy |
GroupedDBID | --- -Q- .55 .XZ 0R~ 29L 2WC 36B 39C 3V. 4.4 406 53G 5GY 5RE 70F 7RV 7X7 88E 8AO 8C1 8FI 8FJ 8R4 8R5 AACDK AANZL AAQQT AASDW AASML AATNV AAWTL AAYZH AAZLF ABAKF ABAWZ ABDBF ABJNI ABLJU ABOCM ABUWG ABZZP ACAOD ACGFO ACGFS ACKTT ACMJI ACPRK ACRQY ACUHS ACZOJ ADBBV ADHDB AEFQL AEJRE AEMSY AENEX AEVLU AEXYK AFBBN AFFNX AFKRA AFRAH AFSHS AGAYW AGHAI AGQEE AHMBA AHSBF AIGIU AILAN AJRNO ALFFA ALIPV ALMA_UNASSIGNED_HOLDINGS AMYLF ASPBG AVWKF AXYYD AZFZN B0M BAWUL BBNVY BENPR BHPHI BKEYQ BKKNO BPHCQ BVXVI CAG CCPQU COF CS3 DIK DNIVK DPUIP DU5 E3Z EAD EAP EBC EBD EBLON EBS EBX EE. EIOEI EJD EMB EMK EMOBN EPL ESX EX3 F5P FDQFY FEDTE FERAY FIGPU FIZPM FSGXE FYUFA HCIFZ HMCUK HVGLF HZ~ IAO IH2 IHR IHW INH INR ITC IWAJR JSO JZLTJ KQ8 LGEZI LOTEE M1P M7P N9A NADUK NAO NAPCQ NQJWS NXXTH O9- OK1 OVD P2P P6G PQQKQ PROAC PSQYO Q2X RNS RNT RNTTT ROL SNX SNYQT SOHCF SOJ SRMVM SV3 SWTZT TAOOD TBHMF TDRGL TEORI TR2 TSG TUS UDS UKHRP WOW X7M Y6R ZGI ZXP ~8M AAYXX ABBRH ABDBE ABFSG ABRTQ ACSTC AEZWR AFDZB AFHIU AHWEU AIXLP ATHPR AYFIA CITATION PHGZM PHGZT PJZUB PPXIY PQGLB PUEGO IQODW CGR CUY CVF ECM EIF NPM ACMFV AEIIB PMFND 7QL 7T5 7T7 7TM 7TO 7U9 7XB 8FD 8FE 8FH 8FK AZQEC C1K DWQXO FR3 GNUQQ H94 K9. LK8 M7N P64 PKEHL PQEST PQUKI PRINS 7X8 ADTOC UNPAY |
ID | FETCH-LOGICAL-c577t-2062c232e56a3e983c2478a8e31a4325286a80922a9cf11e7be3e2eccbd9672b3 |
IEDL.DBID | UNPAY |
ISSN | 0887-6924 1476-5551 |
IngestDate | Wed Oct 01 15:27:32 EDT 2025 Sun Sep 28 00:41:01 EDT 2025 Sun Sep 28 07:02:02 EDT 2025 Fri Jul 25 08:57:23 EDT 2025 Sat Aug 23 13:07:08 EDT 2025 Tue Jun 17 21:07:19 EDT 2025 Tue Jun 10 20:26:43 EDT 2025 Thu May 22 21:22:33 EDT 2025 Wed Feb 19 01:51:59 EST 2025 Mon Jul 21 09:17:19 EDT 2025 Wed Oct 01 03:37:31 EDT 2025 Thu Apr 24 23:09:44 EDT 2025 Fri Feb 21 02:37:57 EST 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Keywords | chronic lymphocytic leukemia immunoglobulin mutational status tumor microenvironment Human Heavy peptide chain Immunoglobulins Hematology Variable region Spontaneous Cell microenvironment Malignant hemopathy B-Lymphocyte Signal transduction Chronic lymphocytic leukemia Cell death Lymphoproliferative syndrome Environment Genetics Mutation Cancer Apoptosis |
Language | English |
License | CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c577t-2062c232e56a3e983c2478a8e31a4325286a80922a9cf11e7be3e2eccbd9672b3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 |
OpenAccessLink | https://proxy.k.utb.cz/login?url=https://www.nature.com/articles/leu201112.pdf |
PMID | 21372840 |
PQID | 2645728303 |
PQPubID | 30521 |
PageCount | 10 |
ParticipantIDs | unpaywall_primary_10_1038_leu_2011_12 proquest_miscellaneous_874184916 proquest_miscellaneous_866251350 proquest_journals_865711284 proquest_journals_2645728303 gale_infotracmisc_A257125817 gale_infotracacademiconefile_A257125817 gale_healthsolutions_A257125817 pubmed_primary_21372840 pascalfrancis_primary_24166145 crossref_primary_10_1038_leu_2011_12 crossref_citationtrail_10_1038_leu_2011_12 springer_journals_10_1038_leu_2011_12 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2011-05-01 |
PublicationDateYYYYMMDD | 2011-05-01 |
PublicationDate_xml | – month: 05 year: 2011 text: 2011-05-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: Avenel, NJ – name: England |
PublicationTitle | Leukemia |
PublicationTitleAbbrev | Leukemia |
PublicationTitleAlternate | Leukemia |
PublicationYear | 2011 |
Publisher | Nature Publishing Group UK Nature Publishing Group |
Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group |
References | Hamblin, Davis, Gardiner, Oscier, Stevenson (CR3) 1999; 94 Damle, Wasil, Fais, Ghiotto, Valetto, Allen (CR2) 1999; 94 Kurtova, Balakrishnan, Chen, Ding, Schnabl, Quiroga (CR8) 2009; 114 Tsukada, Burger, Zvaifler, Kipps (CR11) 2002; 99 Burger, Ghia, Rosenwald, Caligaris-Cappio (CR12) 2009; 114 Rezvany, Jeddi-Tehrani, Wigzell, Osterborg, Mellstedt (CR37) 2003; 101 Caligaris-Cappio, Ghia (CR4) 2008; 26 Lanham, Hamblin, Oscier, Ibbotson, Stevenson, Packham (CR47) 2003; 101 Coope, Atkinson, Huhse, Belich, Janzen, Holman (CR29) 2002; 21 Packham, Stevenson (CR18) 2005; 114 Ghia, Chiorazzi, Stamatopoulos (CR1) 2008; 264 Ghia, Circosta, Scielzo, Vallario, Camporeale, Granziero (CR9) 2005; 294 Bojarska-Junak, Rolinski, Wasik-Szczepaneko, Kaluzny, Dmoszynska (CR42) 2002; 87 Petlickovski, Laurenti, Li, Marietti, Chiusolo, Sica (CR23) 2005; 105 Bonizzi, Karin (CR25) 2004; 25 Ricca, Rocci, Drandi, Francese, Compagno, Lobetti Bodoni (CR19) 2007; 21 Nishio, Endo, Tsukada, Ohata, Kitada, Reed (CR35) 2005; 106 Dancescu, Rubio-Trujillo, Biron, Bron, Delespesse, Sarfati (CR31) 1992; 176 Fahey, Schaefer, Channon, Wira (CR22) 2005; 20 Gorgun, Holderried, Zahrieh, Neuberg, Gribben (CR41) 2005; 115 Vallabhapurapu, Karin (CR26) 2009; 27 Mitsiades, Mitsiades, Koutsilieris (CR45) 2004; 4 Burger, Tsukada, Burger, Zvaifler, Dell’Aquila, Kipps (CR10) 2000; 96 Furman, Asgary, Mascarenhas, Liou, Schattner (CR17) 2000; 164 Francia di Celle, Mariani, Riera, Stacchini, Reato, Foa (CR44) 1996; 87 Hewamana, Lin, Jenkins, Burnett, Jordan, Fegan (CR48) 2008; 14 Deaglio, Vaisitti, Aydin, Bergui, D’Arena, Bonello (CR32) 2007; 110 de Oliveira Pinto, Garcia, Lecoeur, Rapp, Gougeon (CR20) 2002; 99 Chiorazzi, Rai, Ferrarini (CR38) 2005; 352 Ho, Hsu, Phyliky, Li (CR43) 2005; 114 Haiat, Billard, Quiney, Ajchenbaum-Cymbalista, Kolb (CR14) 2006; 118 Burger, Hartmann, Krome, Rawluk, Tamamura, Fujii (CR33) 2005; 106 Senftleben, Cao, Xiao, Greten, Krähn, Bonizzi (CR27) 2001; 293 Burger, Ghia, Rosenwald, Caligaris-Cappio (CR36) 2009; 114 Yilmaz, Weih, Sivakumar, Weih (CR28) 2003; 22 Ranheim, Kipps (CR13) 1993; 177 Hewamana, Alghazal, Lin, Clement, Jenkins, Guzman (CR24) 2008; 111 Tinhofer, Weiss, Gassner, Rubenzer, Holler, Greil (CR40) 2009; 32 Claudio, Brown, Park, Wang, Siebenlist (CR30) 2002; 3 Lagneaux, Delforge, Bron, De Bruyn, Stryckmans (CR5) 1998; 91 Röth, de Beer, Nückel, Sellmann, Dührsen, Dürig (CR39) 2008; 143 Hewamana, Lin, Rowntree, Karunanithi, Pratt, Hills (CR16) 2009; 27 Manna, Ramesh (CR46) 2005; 280 Burger, Kipps (CR7) 2006; 107 Zaninoni, Imperiali, Pasquini, Zanella, Barcellini (CR15) 2003; 31 Hegde, Peterson, Emanuel, Mittal, Joshi, Dickinson (CR34) 2008; 6 Panayiotidis, Jones, Ganeshaguru, Foroni, Hoffbrand (CR6) 1996; 92 Riganti, Orecchia, Pescarmona, Betta, Ghigo, Bosia (CR21) 2006; 119 N Tsukada (BFleu201112_CR11) 2002; 99 G Gorgun (BFleu201112_CR41) 2005; 115 S Haiat (BFleu201112_CR14) 2006; 118 S Hewamana (BFleu201112_CR48) 2008; 14 EA Ranheim (BFleu201112_CR13) 1993; 177 S Hewamana (BFleu201112_CR24) 2008; 111 AV Kurtova (BFleu201112_CR8) 2009; 114 LM de Oliveira Pinto (BFleu201112_CR20) 2002; 99 JA Burger (BFleu201112_CR10) 2000; 96 GV Hegde (BFleu201112_CR34) 2008; 6 HJ Coope (BFleu201112_CR29) 2002; 21 A Bojarska-Junak (BFleu201112_CR42) 2002; 87 JA Burger (BFleu201112_CR12) 2009; 114 S Vallabhapurapu (BFleu201112_CR26) 2009; 27 E Claudio (BFleu201112_CR30) 2002; 3 M Burger (BFleu201112_CR33) 2005; 106 A Röth (BFleu201112_CR39) 2008; 143 JV Fahey (BFleu201112_CR22) 2005; 20 I Tinhofer (BFleu201112_CR40) 2009; 32 M Nishio (BFleu201112_CR35) 2005; 106 P Francia di Celle (BFleu201112_CR44) 1996; 87 TJ Hamblin (BFleu201112_CR3) 1999; 94 A Petlickovski (BFleu201112_CR23) 2005; 105 ZB Yilmaz (BFleu201112_CR28) 2003; 22 JA Burger (BFleu201112_CR36) 2009; 114 G Bonizzi (BFleu201112_CR25) 2004; 25 P Ghia (BFleu201112_CR9) 2005; 294 C Riganti (BFleu201112_CR21) 2006; 119 N Chiorazzi (BFleu201112_CR38) 2005; 352 I Ricca (BFleu201112_CR19) 2007; 21 U Senftleben (BFleu201112_CR27) 2001; 293 G Packham (BFleu201112_CR18) 2005; 114 CS Mitsiades (BFleu201112_CR45) 2004; 4 P Panayiotidis (BFleu201112_CR6) 1996; 92 S Deaglio (BFleu201112_CR32) 2007; 110 MR Rezvany (BFleu201112_CR37) 2003; 101 S Hewamana (BFleu201112_CR16) 2009; 27 F Caligaris-Cappio (BFleu201112_CR4) 2008; 26 P Ghia (BFleu201112_CR1) 2008; 264 JA Burger (BFleu201112_CR7) 2006; 107 S Lanham (BFleu201112_CR47) 2003; 101 L Lagneaux (BFleu201112_CR5) 1998; 91 RN Damle (BFleu201112_CR2) 1999; 94 CL Ho (BFleu201112_CR43) 2005; 114 SK Manna (BFleu201112_CR46) 2005; 280 A Zaninoni (BFleu201112_CR15) 2003; 31 M Dancescu (BFleu201112_CR31) 1992; 176 RR Furman (BFleu201112_CR17) 2000; 164 |
References_xml | – volume: 4 start-page: 235 year: 2004 end-page: 256 ident: CR45 article-title: The Akt pathway: molecular targets for anti-cancer drug development publication-title: Curr Cancer Drug Targets doi: 10.2174/1568009043333032 – volume: 101 start-page: 1087 year: 2003 end-page: 1093 ident: CR47 article-title: Differential signaling via surface IgM is associated with VH gene mutational status and CD38 expression in chronic lymphocytic leukemia publication-title: Blood doi: 10.1182/blood-2002-06-1822 – volume: 22 start-page: 121 year: 2003 end-page: 130 ident: CR28 article-title: RelB is required for Peyer's patch development: differential regulation of p52-RelB by lymphotoxin and TNF publication-title: EMBO J doi: 10.1093/emboj/cdg004 – volume: 27 start-page: 693 year: 2009 end-page: 733 ident: CR26 article-title: Regulation and function of NF-kappaB transcription factors in the immune system publication-title: Annu Rev Immunol doi: 10.1146/annurev.immunol.021908.132641 – volume: 115 start-page: 1797 year: 2005 end-page: 1805 ident: CR41 article-title: Chronic lymphocytic leukemia cells induce changes in gene expression of CD4 and CD8T cells publication-title: J Clin Invest doi: 10.1172/JCI24176 – volume: 27 start-page: 763 year: 2009 end-page: 769 ident: CR16 article-title: Rel a is an independent biomarker of clinical outcome in chronic lymphocytic leukemia publication-title: J Clin Oncol doi: 10.1200/JCO.2008.19.1114 – volume: 352 start-page: 804 year: 2005 end-page: 815 ident: CR38 article-title: Chronic lymphocytic leukemia publication-title: N Engl J Med doi: 10.1056/NEJMra041720 – volume: 164 start-page: 2200 year: 2000 end-page: 2206 ident: CR17 article-title: Modulation of NF-kappa B activity and apoptosis in chronic lymphocytic leukemia B cells publication-title: J Immunol doi: 10.4049/jimmunol.164.4.2200 – volume: 119 start-page: 17 year: 2006 end-page: 27 ident: CR21 article-title: Statins revert doxorubicin resistance via nitric oxide in malignant mesothelioma publication-title: Int J Cancer doi: 10.1002/ijc.21832 – volume: 3 start-page: 958 year: 2002 end-page: 965 ident: CR30 article-title: BAFF-induced NEMO-independent processing of NF-κB2 in maturing B cells publication-title: Nat Immunol doi: 10.1038/ni842 – volume: 114 start-page: 3367 year: 2009 end-page: 3375 ident: CR12 article-title: The microenvironment in mature B-cell malignancies: a target for new treatment strategies publication-title: Blood doi: 10.1182/blood-2009-06-225326 – volume: 110 start-page: 4012 year: 2007 end-page: 4021 ident: CR32 article-title: CD38 and ZAP-70 are functionally linked and mark CLL B cells with high migratory potential publication-title: Blood doi: 10.1182/blood-2007-06-094029 – volume: 32 start-page: 302 year: 2009 end-page: 309 ident: CR40 article-title: Difference in the relative distribution of CD4+ T-cell subsets in B-CLL with mutated and unmutated immunoglobulin (Ig) VH genes: implication for the course of disease publication-title: J Immunother doi: 10.1097/CJI.0b013e318197b5e4 – volume: 280 start-page: 7010 year: 2005 end-page: 7021 ident: CR46 article-title: Interleukin-8 induces nuclear transcription factor-kappaB through a TRAF6-dependent pathway publication-title: J Biol Chem doi: 10.1074/jbc.M410994200 – volume: 118 start-page: 281 year: 2006 end-page: 292 ident: CR14 article-title: Role of BAFF and APRIL in human B-cell chronic lymphocytic leukemia publication-title: Immunology doi: 10.1111/j.1365-2567.2006.02377.x – volume: 177 start-page: 925 year: 1993 end-page: 935 ident: CR13 article-title: Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal publication-title: J Exp Med doi: 10.1084/jem.177.4.925 – volume: 105 start-page: 4820 year: 2005 end-page: 4827 ident: CR23 article-title: Sustained signaling through the B-cell receptor induces Mcl-1 and promotes survival of chronic lymphocytic leukemia B cells publication-title: Blood doi: 10.1182/blood-2004-07-2669 – volume: 114 start-page: 3367 year: 2009 end-page: 3375 ident: CR36 article-title: The microenvironment in mature B-cell malignancies: a target for new treatment strategies publication-title: Blood doi: 10.1182/blood-2009-06-225326 – volume: 143 start-page: 383 year: 2008 end-page: 386 ident: CR39 article-title: Significantly shorter telomeres in T-cells of patients with ZAP-70+/CD38+ chronic lymphocytic leukemia publication-title: Br J Haematol doi: 10.1111/j.1365-2141.2008.07363.x – volume: 107 start-page: 1761 year: 2006 end-page: 1767 ident: CR7 article-title: CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment publication-title: Blood doi: 10.1182/blood-2005-08-3182 – volume: 99 start-page: 1030 year: 2002 end-page: 1037 ident: CR11 article-title: Distinctive features of ‘nurselike’ cells that differentiate in the context of chronic lymphocytic leukemia publication-title: Blood doi: 10.1182/blood.V99.3.1030 – volume: 21 start-page: 5375 year: 2002 end-page: 5385 ident: CR29 article-title: CD40 regulates the processing of NF-κB2 p100 to p 52 publication-title: EMBO J doi: 10.1093/emboj/cdf542 – volume: 6 start-page: 1928 year: 2008 end-page: 1936 ident: CR34 article-title: Hedgehog-induced survival of B-cell chronic lymphocytic leukemia cells in a stromal cell microenvironment: a potential new therapeutic target publication-title: Mol Cancer Res doi: 10.1158/1541-7786.MCR-08-0142 – volume: 92 start-page: 97 year: 1996 end-page: 103 ident: CR6 article-title: Human bone marrow stromal cells prevent apoptosis and support the survival of chronic lymphocytic leukemia cells publication-title: Br J Haematol doi: 10.1046/j.1365-2141.1996.00305.x – volume: 106 start-page: 1824 year: 2005 end-page: 1830 ident: CR33 article-title: Small peptide inhibitors of the CXCR4 chemokine receptor (CD184) antagonize the activation, migration, and antiapoptotic responses of CXCL12 in chronic lymphocytic leukemia B cells publication-title: Blood doi: 10.1182/blood-2004-12-4918 – volume: 114 start-page: 133 year: 2005 end-page: 140 ident: CR43 article-title: Autocrine expression of platelet-derived growth factor B in B cell chronic lymphocytic leukemia publication-title: Acta Haematol doi: 10.1159/000087886 – volume: 94 start-page: 1840 year: 1999 end-page: 1847 ident: CR2 article-title: Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia publication-title: Blood – volume: 91 start-page: 2387 year: 1998 end-page: 2396 ident: CR5 article-title: Chronic lymphocytic leukemic B cells but not normal B cells are rescued from apoptosis by contact with normal bone marrow stromal cells publication-title: Blood – volume: 293 start-page: 1495 year: 2001 end-page: 1499 ident: CR27 article-title: Activation by IKKα of a second, evolutionary conserved, NF-κB signaling pathway publication-title: Science doi: 10.1126/science.1062677 – volume: 294 start-page: 135 year: 2005 end-page: 145 ident: CR9 article-title: Differential effects on CLL cell survival exerted by different microenvironmental elements publication-title: Curr Top Microbiol Immunol – volume: 31 start-page: 185 year: 2003 end-page: 190 ident: CR15 article-title: Cytokine modulation of nuclear factor-kappaB activity in B-chronic lymphocytic leukemia publication-title: Exp Hematol doi: 10.1016/S0301-472X(02)01046-9 – volume: 264 start-page: 549 year: 2008 end-page: 562 ident: CR1 article-title: Microenvironmental influences in chronic lymphocytic leukemia: the role of antigen stimulation publication-title: J Intern Med doi: 10.1111/j.1365-2796.2008.02030.x – volume: 101 start-page: 1063 year: 2003 end-page: 1070 ident: CR37 article-title: Leukemia-associated monoclonal and oligoclonal TCR-BV use in patients with B-cell chronic lymphocytic leukemia publication-title: Blood doi: 10.1182/blood-2002-03-0746 – volume: 20 start-page: 1439 year: 2005 end-page: 1446 ident: CR22 article-title: Secretion of cytokines and chemokines by polarized human epithelial cells from the female reproductive tract publication-title: Hum Reprod doi: 10.1093/humrep/deh806 – volume: 114 start-page: 4441 year: 2009 end-page: 4450 ident: CR8 article-title: Diverse marrow stromal cells protect CLL B cells from spontaneous and drug-induced apoptosis: development of a reliable and reproducible system to assess stromal cell adhesion-mediated drug resistance publication-title: Blood doi: 10.1182/blood-2009-07-233718 – volume: 96 start-page: 2655 year: 2000 end-page: 2663 ident: CR10 article-title: Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1 publication-title: Blood – volume: 26 start-page: 4497 year: 2008 end-page: 4503 ident: CR4 article-title: Novel insights in chronic lymphocytic leukemia: are we coming closer to understanding the pathogenesis of the disease? publication-title: J Clin Oncol doi: 10.1200/JCO.2007.15.4393 – volume: 111 start-page: 4681 year: 2008 end-page: 4689 ident: CR24 article-title: The NF-kappaB subunit Rel A is associated with survival and clinical disease progression in chronic lymphocytic leukemia and represents a promising therapeutic target publication-title: Blood doi: 10.1182/blood-2007-11-125278 – volume: 87 start-page: 490 year: 2002 end-page: 499 ident: CR42 article-title: Intracellular tumor necrosis factor production by T- and B-cells in B-cell chronic lymphocytic leukemia publication-title: Haematologica – volume: 14 start-page: 8102 year: 2008 end-page: 8111 ident: CR48 article-title: The novel nuclear factor-kappaB inhibitor LC-1 is equipotent in poor prognostic subsets of chronic lymphocytic leukemia and shows strong synergy with fludarabine publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-08-1673 – volume: 94 start-page: 1848 year: 1999 end-page: 1854 ident: CR3 article-title: Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia publication-title: Blood – volume: 21 start-page: 697 year: 2007 end-page: 705 ident: CR19 article-title: Telomere length identifies two different prognostic subgroups among VH-unmutated B-cell chronic lymphocytic leukemia patients publication-title: Leukemia doi: 10.1038/sj.leu.2404544 – volume: 99 start-page: 1666 year: 2002 end-page: 1675 ident: CR20 article-title: Increased sensitivity of T lymphocytes to tumor necrosis factor receptor 1 (TNFR1)- and TNFR2-mediated apoptosis in HIV infection: relation to expression of Bcl-2 and active caspase-8 and caspase-3 publication-title: Blood doi: 10.1182/blood.V99.5.1666 – volume: 114 start-page: 441 year: 2005 end-page: 449 ident: CR18 article-title: Bodyguards and assassins: Bcl-2 family proteins and apoptosis control in chronic lymphocytic leukemia publication-title: Immunology doi: 10.1111/j.1365-2567.2005.02117.x – volume: 176 start-page: 1319 year: 1992 end-page: 1326 ident: CR31 article-title: Interleukin 4 protects chronic lymphocytic leukemic B cells from death by apoptosis and upregulates Bcl-2 expression publication-title: J Exp Med doi: 10.1084/jem.176.5.1319 – volume: 106 start-page: 1012 year: 2005 end-page: 1020 ident: CR35 article-title: Nurselike cells express BAFF and APRIL, which can promote survival of chronic lymphocytic leukemia cells via a paracrine pathway distinct from that of SDF-1alpha publication-title: Blood doi: 10.1182/blood-2004-03-0889 – volume: 25 start-page: 280 year: 2004 end-page: 288 ident: CR25 article-title: The two NF-κB activation pathways and their role in innate and adaptive immunity publication-title: Trends Immunol doi: 10.1016/j.it.2004.03.008 – volume: 87 start-page: 4382 year: 1996 end-page: 4389 ident: CR44 article-title: Interleukin-8 induces the accumulation of B-cell chronic lymphocytic leukemia cells by prolonging survival in an autocrine fashion publication-title: Blood – volume: 32 start-page: 302 year: 2009 ident: BFleu201112_CR40 publication-title: J Immunother doi: 10.1097/CJI.0b013e318197b5e4 – volume: 114 start-page: 3367 year: 2009 ident: BFleu201112_CR12 publication-title: Blood doi: 10.1182/blood-2009-06-225326 – volume: 280 start-page: 7010 year: 2005 ident: BFleu201112_CR46 publication-title: J Biol Chem doi: 10.1074/jbc.M410994200 – volume: 114 start-page: 133 year: 2005 ident: BFleu201112_CR43 publication-title: Acta Haematol doi: 10.1159/000087886 – volume: 6 start-page: 1928 year: 2008 ident: BFleu201112_CR34 publication-title: Mol Cancer Res doi: 10.1158/1541-7786.MCR-08-0142 – volume: 87 start-page: 490 year: 2002 ident: BFleu201112_CR42 publication-title: Haematologica – volume: 96 start-page: 2655 year: 2000 ident: BFleu201112_CR10 publication-title: Blood doi: 10.1182/blood.V96.8.2655 – volume: 27 start-page: 693 year: 2009 ident: BFleu201112_CR26 publication-title: Annu Rev Immunol doi: 10.1146/annurev.immunol.021908.132641 – volume: 99 start-page: 1030 year: 2002 ident: BFleu201112_CR11 publication-title: Blood doi: 10.1182/blood.V99.3.1030 – volume: 22 start-page: 121 year: 2003 ident: BFleu201112_CR28 publication-title: EMBO J doi: 10.1093/emboj/cdg004 – volume: 20 start-page: 1439 year: 2005 ident: BFleu201112_CR22 publication-title: Hum Reprod doi: 10.1093/humrep/deh806 – volume: 294 start-page: 135 year: 2005 ident: BFleu201112_CR9 publication-title: Curr Top Microbiol Immunol – volume: 115 start-page: 1797 year: 2005 ident: BFleu201112_CR41 publication-title: J Clin Invest doi: 10.1172/JCI24176 – volume: 25 start-page: 280 year: 2004 ident: BFleu201112_CR25 publication-title: Trends Immunol doi: 10.1016/j.it.2004.03.008 – volume: 143 start-page: 383 year: 2008 ident: BFleu201112_CR39 publication-title: Br J Haematol doi: 10.1111/j.1365-2141.2008.07363.x – volume: 111 start-page: 4681 year: 2008 ident: BFleu201112_CR24 publication-title: Blood doi: 10.1182/blood-2007-11-125278 – volume: 94 start-page: 1848 year: 1999 ident: BFleu201112_CR3 publication-title: Blood doi: 10.1182/blood.V94.6.1848 – volume: 114 start-page: 441 year: 2005 ident: BFleu201112_CR18 publication-title: Immunology doi: 10.1111/j.1365-2567.2005.02117.x – volume: 177 start-page: 925 year: 1993 ident: BFleu201112_CR13 publication-title: J Exp Med doi: 10.1084/jem.177.4.925 – volume: 21 start-page: 697 year: 2007 ident: BFleu201112_CR19 publication-title: Leukemia doi: 10.1038/sj.leu.2404544 – volume: 110 start-page: 4012 year: 2007 ident: BFleu201112_CR32 publication-title: Blood doi: 10.1182/blood-2007-06-094029 – volume: 264 start-page: 549 year: 2008 ident: BFleu201112_CR1 publication-title: J Intern Med doi: 10.1111/j.1365-2796.2008.02030.x – volume: 107 start-page: 1761 year: 2006 ident: BFleu201112_CR7 publication-title: Blood doi: 10.1182/blood-2005-08-3182 – volume: 176 start-page: 1319 year: 1992 ident: BFleu201112_CR31 publication-title: J Exp Med doi: 10.1084/jem.176.5.1319 – volume: 92 start-page: 97 year: 1996 ident: BFleu201112_CR6 publication-title: Br J Haematol doi: 10.1046/j.1365-2141.1996.00305.x – volume: 87 start-page: 4382 year: 1996 ident: BFleu201112_CR44 publication-title: Blood doi: 10.1182/blood.V87.10.4382.bloodjournal87104382 – volume: 94 start-page: 1840 year: 1999 ident: BFleu201112_CR2 publication-title: Blood doi: 10.1182/blood.V94.6.1840 – volume: 27 start-page: 763 year: 2009 ident: BFleu201112_CR16 publication-title: J Clin Oncol doi: 10.1200/JCO.2008.19.1114 – volume: 101 start-page: 1087 year: 2003 ident: BFleu201112_CR47 publication-title: Blood doi: 10.1182/blood-2002-06-1822 – volume: 31 start-page: 185 year: 2003 ident: BFleu201112_CR15 publication-title: Exp Hematol doi: 10.1016/S0301-472X(02)01046-9 – volume: 164 start-page: 2200 year: 2000 ident: BFleu201112_CR17 publication-title: J Immunol doi: 10.4049/jimmunol.164.4.2200 – volume: 99 start-page: 1666 year: 2002 ident: BFleu201112_CR20 publication-title: Blood doi: 10.1182/blood.V99.5.1666 – volume: 119 start-page: 17 year: 2006 ident: BFleu201112_CR21 publication-title: Int J Cancer doi: 10.1002/ijc.21832 – volume: 21 start-page: 5375 year: 2002 ident: BFleu201112_CR29 publication-title: EMBO J doi: 10.1093/emboj/cdf542 – volume: 106 start-page: 1824 year: 2005 ident: BFleu201112_CR33 publication-title: Blood doi: 10.1182/blood-2004-12-4918 – volume: 106 start-page: 1012 year: 2005 ident: BFleu201112_CR35 publication-title: Blood doi: 10.1182/blood-2004-03-0889 – volume: 114 start-page: 4441 year: 2009 ident: BFleu201112_CR8 publication-title: Blood doi: 10.1182/blood-2009-07-233718 – volume: 3 start-page: 958 year: 2002 ident: BFleu201112_CR30 publication-title: Nat Immunol doi: 10.1038/ni842 – volume: 293 start-page: 1495 year: 2001 ident: BFleu201112_CR27 publication-title: Science doi: 10.1126/science.1062677 – volume: 114 start-page: 3367 year: 2009 ident: BFleu201112_CR36 publication-title: Blood doi: 10.1182/blood-2009-06-225326 – volume: 91 start-page: 2387 year: 1998 ident: BFleu201112_CR5 publication-title: Blood doi: 10.1182/blood.V91.7.2387 – volume: 4 start-page: 235 year: 2004 ident: BFleu201112_CR45 publication-title: Curr Cancer Drug Targets doi: 10.2174/1568009043333032 – volume: 26 start-page: 4497 year: 2008 ident: BFleu201112_CR4 publication-title: J Clin Oncol doi: 10.1200/JCO.2007.15.4393 – volume: 14 start-page: 8102 year: 2008 ident: BFleu201112_CR48 publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-08-1673 – volume: 352 start-page: 804 year: 2005 ident: BFleu201112_CR38 publication-title: N Engl J Med doi: 10.1056/NEJMra041720 – volume: 101 start-page: 1063 year: 2003 ident: BFleu201112_CR37 publication-title: Blood doi: 10.1182/blood-2002-03-0746 – volume: 105 start-page: 4820 year: 2005 ident: BFleu201112_CR23 publication-title: Blood doi: 10.1182/blood-2004-07-2669 – volume: 118 start-page: 281 year: 2006 ident: BFleu201112_CR14 publication-title: Immunology doi: 10.1111/j.1365-2567.2006.02377.x |
SSID | ssj0014766 |
Score | 2.2683108 |
Snippet | Tumor cells in chronic lymphocytic leukemia (CLL) are more prone to apoptosis when cultured
ex vivo,
because they lack prosurvival signals furnished
in vivo... Tumor cells in chronic lymphocytic leukemia (CLL) are more prone to apoptosis when cultured ex vivo, because they lack prosurvival signals furnished in vivo... |
SourceID | unpaywall proquest gale pubmed pascalfrancis crossref springer |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 828 |
SubjectTerms | 631/208/737 631/80/82/23 692/699/67/1990/283/1895 Adult Aged Aged, 80 and over Apoptosis B cells B-cell receptor B-Lymphocytes - metabolism B-Lymphocytes - pathology Bcl-2 protein Biological and medical sciences Blotting, Western Bone marrow Cancer Research CD40 antigen CD40 Ligand - metabolism Chronic lymphocytic leukemia Critical Care Medicine Cytokines Development and progression Electrophoretic Mobility Shift Assay Female Genetic aspects Health aspects Hematologic and hematopoietic diseases Hematology Humans Immunoglobulin Heavy Chains - genetics Immunoglobulin Variable Region - genetics Immunoglobulins In vivo methods and tests Intensive Interleukin 4 Internal Medicine Laboratories Leukemia Leukemia, Lymphocytic, Chronic, B-Cell - genetics Leukemia, Lymphocytic, Chronic, B-Cell - immunology Leukemia, Lymphocytic, Chronic, B-Cell - pathology Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis Leukocytes (mononuclear) Ligands Lymphatic leukemia Lymphocytes Lymphocytes B Lymphocytes T Lymphoma Male Medical sciences Medicine Medicine & Public Health Middle Aged Mutation - genetics NF-kappa B - genetics NF-kappa B - metabolism NF-κB protein Oncology original-article Peripheral blood mononuclear cells Physiological aspects Proto-Oncogene Proteins c-bcl-2 - metabolism Receptors, Antigen, B-Cell - metabolism Signal Transduction Stromal cells Therapeutic applications Tumor cells Tumor Cells, Cultured |
SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fi9QwEA56gp6I-Nt655mHOwShXNO0Sfok5-G5yumTJ_tW0iQFYW171xbxf_CPdqbNdndx2beFTHbS5JvJl2QyIeRYlrosYGIORWSjMBHMhoUVmIuQFTxxpSrHaItvYnaVfJmnc7_h1vqwyqVPHBy1rQ3ukZ_CxJ1KzFbF3zfXIb4ahaer_gmN2-QOA6qCqJbzacHFEjmeVaIhCVho-Pt5EVenC9eP-TtZvDEjeb_8oNEt9FE5Pm6xjX2unZzeJ_f6qtF_fuvFYm1yunhEHnpWSc9GGDwmt1z1hNz96s_Nn5K_nz_NftC--tUjt7T0_PKSfqC4ad9SfeMoRttSUF452tUUo2aBM7q6h9Kmbrq6_Qm_KkvbvsB9GxRauyEHmqFu24PXAdxSDAkBUFPclKdbND4jVxcfv5_PQv8OQ2hSKTswJBEbYF4uFZq7THETJ1Jp5TjTCY_TWAmtoiyOdWZKxpwsHHcxYKOwmZBxwZ-TvQq-4CWhWSmVMVmEV4wSm8FEIS23mC40cgqoYEDeLcciNz5JOb6VsciHw3Kuchi4HAcuZyB8PAk3Y26O7WJvcFDz8WLpZNH5GXgroHeKyYC8HSTQpkGb0f5qArQZs2NtSB5uSIItmo3iow3gTM0CnoREKIX6SyTl3lm0-QraATn4v1gJ-HukEQGhUykqxvC4AQsgAstYxtNohwimKUpgMRCQFyOCV41jHNQnUPlkCemV9q0dejLhfVfHv9r9sQdkf9ygx-jRQ7LX3fTuNTC8rjgazPgfaBpNXg priority: 102 providerName: ProQuest |
Title | IGHV unmutated CLL B cells are more prone to spontaneous apoptosis and subject to environmental prosurvival signals than mutated CLL B cells |
URI | https://link.springer.com/article/10.1038/leu.2011.12 https://www.ncbi.nlm.nih.gov/pubmed/21372840 https://www.proquest.com/docview/2645728303 https://www.proquest.com/docview/865711284 https://www.proquest.com/docview/866251350 https://www.proquest.com/docview/874184916 https://www.nature.com/articles/leu201112.pdf |
UnpaywallVersion | publishedVersion |
Volume | 25 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 1476-5551 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0014766 issn: 1476-5551 databaseCode: KQ8 dateStart: 19970101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVEBS databaseName: Academic Search Ultimate - eBooks customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn eissn: 1476-5551 dateEnd: 20151130 omitProxy: true ssIdentifier: ssj0014766 issn: 1476-5551 databaseCode: ABDBF dateStart: 19970101 isFulltext: true titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn providerName: EBSCOhost – providerCode: PRVLSH databaseName: SpringerLink Journals customDbUrl: mediaType: online eissn: 1476-5551 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0014766 issn: 1476-5551 databaseCode: AFBBN dateStart: 19970101 isFulltext: true providerName: Library Specific Holdings – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1476-5551 dateEnd: 20241004 omitProxy: true ssIdentifier: ssj0014766 issn: 1476-5551 databaseCode: 7X7 dateStart: 19970201 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central Database Suite (ProQuest) customDbUrl: http://www.proquest.com/pqcentral?accountid=15518 eissn: 1476-5551 dateEnd: 20241004 omitProxy: true ssIdentifier: ssj0014766 issn: 1476-5551 databaseCode: BENPR dateStart: 19970201 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Public Health Database customDbUrl: eissn: 1476-5551 dateEnd: 20171231 omitProxy: true ssIdentifier: ssj0014766 issn: 1476-5551 databaseCode: 8C1 dateStart: 19970201 isFulltext: true titleUrlDefault: https://search.proquest.com/publichealth providerName: ProQuest |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3da9swEBdrAvtg7Psja5fpoWUwcGdZtiQ_pqFdNrpQxjKyJyPbMpRmTqhtxvY37I_eXSSnyRZKX0JAp5x0uTv9JN2dCNmXhS5SWJg94ee-FwqWe2kusBYhS3loClXYaIuxGE3CT9No6pLVKxdWaUtaLt10Gx32fmYaXKoYbAPzYod0Bd4ndUh3Mj4bfG-reYrYPmIbSuFFAAVcPp7PFfa39TpZsLECOT98f6ErkElhH7PYhjbXbkrvkTtNudC_furZbG0xOnlIxu00bAzKxWFTp4fZ738qPN54no_IAwdL6cASPCa3TPmE3P7sLt6fkj8fP4y-0ab80SA4zenw9JQeUTz1r6i-NBTDdSkMpzS0nlMMuwXQaeYNtC7mi3pencO3MqdVk-LBDxKtpdgBZ-hbNeC2QPEpxpSAVVA81adbOD4jk5Pjr8OR5x5y8LJIyhosUQQZQDcTCc1NrHgWhFJpZTjTIQ-iQAmt_DgIdJwVjBmZGm4CUK40j4UMUv6cdEqYwUtC40KqLIt9zFEK8xhWGpnzHOuN-kYBluyRd-2fm2Suyjk-tjFLlrftXCUg4QRFnDAg3l8RL2xxj-1kb1BLEpuZunIJyQDcHeBDxWSPvF1SoFMAbpl2uQ0wZiyvtUG5t0EJxpxtNPc3NHE1LABaiKQi6N-qZuK8TZUAqI0kVnLjPbL7f7MS8POIQ3qErlqRMcbXLXUBSGAfzHjkX0OCdY5C2E30yAtrEleDYxzYh9D5oLWRK-5bBXqwMqDrBP_qhnS75K496sc41D3SqS8b8xqwYp32yY6cSvhUQ9Yn3aPj8dmXvvMafwGYK2p2 |
linkProvider | Unpaywall |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3bbtMw1BpDYiCEuI6ysflhFRJStPiS2HlAaAxGy7o9bahvmZM4ElKXhKXRtH_gW_hGzmkubUXVt71F8nGOnXN1zsWEHKjUpBEYZsd3E9eRPkucKPGxFyGLhLSpTutsi3N_cCl_jL3xBvnb1sJgWmWrE2eKOslj_Ed-CIbbU9itSnwufjt4axRGV9srNGq2OLV3t3BkKz8NvwJ9-5yffLs4HjjNrQJO7Ck1BbbweQx-hPV8I2ygRcyl0kZbwYwU3OPaN9oNODdBnDJmVWSF5bDTKAl8xSMB731AHkrhSuzVr8bdAY9JVcdGUXB9ONg09YCu0IcTW9X9QhlfsoCNHXhamBJoktaXaazydhcitU_IVpUV5u7WTCYLxvDkOXnWeLH0qGa7F2TDZi_Jo7MmTv-K_Bl-H_ykVXZdoS-b0OPRiH6hGCQoqbmxFLN7KSDPLJ3mFLN0wUe1eQWjRV5M8_IXPGUJLasI_xMh0EJFHmCGuWUFWg7khGIKCggRxSAAXYHxNbm8Fwq9IZsZ7OAtoUGqdBwHLpY0ySQAw6QSkWB7UtdqcD175GNLizBumqLj3RyTcBacFzoEwoVIuJAB8EEHXNS9QFaD7SNRw7qQtdMg4RFoR3AnNVM98mEGgToEsMWmKYWANWM3riXI3SVIkP14aXhviXG6ZYFfho6XB_NbTgob5VSGc1HqkZ3_h7UPr0e3pUdoN4qIMR1vxgsAAsdmJjx3DQi2RZJw-OiR7ZqD54tjAtBLmNxvWXqOfeUH7Xf8vu7Dv1u_2X2yNbg4G4Wj4fnpDnlcBwcwc3WXbE5vKvsevMtptDcTaUqu7luH_ANFfYk- |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR1db9Mw0BpDGiCE-BxlY_PDKiSkqLGdxM4DQmOjtKxMPDDUt8xJHAmpS8OSaNp_4Bfx67jLV1tR9W1vkXzO2bnzfeQ-TMiRTHQSgmK2PDu2LcdjsRXGHvYiZKFwTKKSOtvi3BtdOF-n7nSL_G1rYTCtspWJlaCO5xH-Ix-A4nYldqsSg6RJi_h-OvyY_bbwBimMtLbXadQscmZub8B9yz-MT4HWfc6Hn3-cjKzmhgErcqUsgEU8HoFNYVxPC-MrEXFHKq2MYNoR3OXK08r2Odd-lDBmZGiE4bDrMPY9yUMB771H7kvhCEwnk9PO2WOOrOOkeIg9cHKa2kBbqMHMlHXvUMZXtGGjEx5nOgf6JPXFGuss36Wo7SPyoEwzfXujZ7MlxTh8Sp40Fi09rlnwGdky6XOy862J2b8gf8ZfRj9pmV6VaNfG9GQyoZ8oBgxyqq8NxUxfCshTQ4s5xYxdsFfNvITRbJ4V8_wXPKUxzcsQ_xkh0FJ1HmCGuXkJEg_ODMV0FDhQFAMCdA3Gl-TiTij0imynsIPXhPqJVFHk21je5MQ-KCkZixhbldpGgRnaI-9bWgRR0yAd7-mYBVWgXqgACBcg4QIGwEcdcFb3BVkPdohEDeqi1k6aBMcgKcG0VEz2yLsKAuUJYIt0UxYBa8bOXCuQ-yuQIAeileGDFcbplgU2GhphLsxvOSloBFUeLI5Vj-z9P6w8eD2aMD1Cu1FEjKl5FS8ACLjQTLj2BhBskeSAI9IjuzUHLxbHBKB3YHK_ZekF9rUftN_x-6YP_2bzZg_JDkiPYDI-P9sjD-s4ASax7pPt4ro0b8HQLMKD6kRTcnnXIuQf_0WNeQ |
linkToUnpaywall | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELegk2AI8f0RNoYfNiFNyojjxHYey8QoaFQ8UDSeIidxJLSSVksiBH8DfzR3tZM1UE17q-Rzz77cnX-2786E7MtSlxkszL4IisCPBCv8rBBYi5BlPDKlKm20xVRMZtHHs_jMJavXLqzSlrRcuekuOuzN3LS4VDHYBhblTbIl8D5pRLZm08_jb101T5HYR2wjKfwYoIDLxwu4wv62XicLByuQ88N3l7oGmZT2MYtNaHPtpvQOud1WS_3rp57P1xajk_tk2k3DxqCcH7VNdpT__qfC47Xn-YDcc7CUji3BQ3LDVI_IrU_u4v0x-fPh_eQrbasfLYLTgh6fntK3FE_9a6ovDMVwXQrDqQxtFhTDbgF0mkULrcvFslnU3-FXVdC6zfDgB4nWUuyAM_StW3BboPgUY0rAKiie6tMNHJ-Q2cm7L8cT3z3k4OexlA1YoghzgG4mFpqbRPE8jKTSynCmIx7GoRJaBUkY6iQvGTMyM9yEoFxZkQgZZvwpGVUwg-eEJqVUeZ4EmKMUFQmsNLLgBdYbDYwCLOmRw-7jprmrco6PbczT1W07VylIOEURpwyI93vipS3usZnsFWpJajNTe5eQjsHdAT5UTHrk9YoCnQJwy7XLbYAxY3mtAeXugBKMOR807w00sR8WAC1EUjH071Qzdd6mTgHUxhIruXGP7PzfrAT8PeIQj9C-FRljfN1KF4AE9sGMx8EVJFjnKILdhEeeWZO4HBzjwD6CzgedjVxy3yjQg96ArhL8i2vS7ZBte9SPcai7ZNRctOYlYMUm23Me4i9zJmco |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=IGHV+unmutated+CLL+B+cells+are+more+prone+to+spontaneous+apoptosis+and+subject+to+environmental+prosurvival+signals+than+mutated+CLL+B+cells&rft.jtitle=Leukemia&rft.au=Coscia%2C+M&rft.au=Griggio%2C+V&rft.au=Vitale%2C+C&rft.au=Boccadoro%2C+M&rft.date=2011-05-01&rft.pub=Nature+Publishing+Group&rft.issn=0887-6924&rft.volume=25&rft.issue=5&rft.spage=828&rft_id=info:doi/10.1038%2Fleu.2011.12&rft.externalDBID=n%2Fa&rft.externalDocID=A257125817 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0887-6924&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0887-6924&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0887-6924&client=summon |